Veru

VERUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$42.626 M

$2.50 +2.46%

Close of 22 Sept 2026

Revenue

$16.9M

#3038 by revenue

Earnings

-$22.7M

Loss-making

Shares outstanding

17,050,320

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#358Werewolf TherapeuticsHOWL$47.7M
#359Grace TherapeuticsGRCE$45.0M
#360VeruVERU$42.6M
#361Nasus PharmaNSRX$41.8M
#362ImmutepIMMP$41.7M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Veru, worth $4.84K. Grants and option exercises are excluded.

K. Gary BarnetteChief Scientific Officer$4.84K
1,800 shares at $2.69 on 13 Aug 2026 · filed 17 Aug 2026

What if Veru were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,773,220

Per share 709,288× higher

Bitcoin $1.74T

$102,147.94

Per share 40,859× higher

Nvidia $5.52T

$323,499.32

Per share 129,400× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Veru are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.